Zylet Articles
Pfizer and B&L to co-promote ophthalmics
9 March 2009
Pharmos gets $12.1M milestone for Zylet launch
7 February 2005
Bausch & Lomb's Zylet OKed in the USA
20 December 2004
Approvable letter for B&L's ophthalmic
16 August 2004
FDA accepts B&L and Pharmos' combo eye filing
10 November 2003
Analyst's Rcommendation For Pharmos
16 December 1996
Showing 1-6 of 6 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
